Merck, Schering-Plough in $42M Vytorin settlement

Merck & Co. and Schering-Plough Corp. said Wednesday they will pay $41.5 million to settle lawsuits claiming the drugmakers, partners on two blockbuster cholesterol drugs, delayed unfavorable study results because they would hurt sales.

Copyright PHILY - Philly.com
Contact Us